Download PDF
CC BY 4.0 · Avicenna J Med
DOI: 10.1055/s-0045-1801865
Review Article

Seroprevalence and Associated Outcomes of Parvovirus B19 Infection in Human Immunodeficiency Virus Patients: A Systematic Review

Sagad O. O. Mohamed 
1   Department of Pediatrics and Child Health, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
,
Reem A. A. Mohamedelmugadam
2   Institute of Endemic Diseases, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
,
Safa A. M. Almardi
3   Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
,
Tassnem H. M. Ahmed
3   Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
,
Malaz E. H. Ibrahim
3   Department of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
,
Abdalla O. O. Mohamedali
4   Department of Internal Medicine, Faculty of Medicine, Shendi University, Shendi, Sudan
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Several case reports have highlighted the presence of serious clinical outcomes in patients with human immunodeficiency virus (HIV) related to parvovirus B19 (PVB19). However, epidemiological studies have produced inconsistent and varying results regarding the prevalence of PVB19 and its associated clinical outcomes in this population. These inconsistencies highlight the need for a thorough summary and analysis of present data to better understand burden and impact of PVB19 on HIV patients. This review aims to provide an overview of current evidence and identify areas for further research.

Following the Meta-analyses of Observational Studies in Epidemiology (MOOSE) guidelines, a comprehensive search was conducted across Medline/PubMed, Google Scholar, and World Health Organization Virtual Health Library Regional Portal. The pooled prevalence with the corresponding 95% confidence interval (CI) was measured using Comprehensive Meta-Analysis Software version 3.3. Publication bias was estimated based on Begg's test, Egger's test, and examination of the funnel plots.

A total of 16 studies, with 2,122 HIV patients, were included in the meta-analysis. The pooled prevalence of detecting anti-PVB19 immunoglobulin G, anti-PVB19 immunoglobulin M, and PVB19 DNA particles among HIV patients was 43.6% (95% CI: 23.5–66.1%), 5.10% (95% CI: 2.10–12.10%), and 6.40% (95% CI: 4.10–9.90%), respectively. In the overall population of HIV patients, most of the included studies did not establish a statistically significant association between PVB19 infection and the occurrence of anemia.

PVB19 infection is commonly detected in individuals with HIV. However, anemia due to PVB19 is not common in this population. Findings from a few studies suggest that PVB19 infection may contribute to anemia in individuals with advanced HIV disease or significant immunosuppression. Additional research is needed to confirm and clarify these relationships in individuals with HIV, particularly those with compromised immune systems.

Keywords

human immunodeficiency virus - HIV - anemia - parvovirus B19 - PVB19


Publication History

Article published online:
27 January 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Le Hingrat Q, Sereti I, Landay AL, Pandrea I, Apetrei C. The Hitchhiker Guide to CD4+ T-cell depletion in lentiviral infection. a critical review of the dynamics of the CD4+ T cells in SIV and HIV infection. Front Immunol 2021; 12: 695674
    CrossrefPubMedSearch in Google Scholar
  • 2 German Advisory Committee Blood (Arbeitskreis Blut), Subgroup ‘Assessment of Pathogens Transmissible by Blood’. Human Immunodeficiency Virus (HIV). Transfus Med Hemother 2016; 43 (03) 203-222
    CrossrefPubMedSearch in Google Scholar
  • 3 Nasir IA, Medugu T, Dangana A. Human parvovirus B19-associated hematopathy in HIV disease: need for clinicopathological revisit. J Biomed Res 2018; 32 (01) 1-2
    CrossrefPubMedSearch in Google Scholar
  • 4 Abkowitz JL, Brown KE, Wood RW, Kovach NL, Green SW, Young NS. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 1997; 176 (01) 269-273
    CrossrefPubMedSearch in Google Scholar
  • 5 Ashaka OS, Salu OB, James AB. et al. Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study. Afr Health Sci 2020; 20 (01) 219-226
    CrossrefPubMedSearch in Google Scholar
  • 6 Setúbal S, Jorge-Pereira MC, de Sant'Anna AL, de Oliveira SA, Bazin AR, do Nascimento JP. Clinical presentation of parvovirus B19 infection in HIV-infected patients with and without AIDS. Rev Soc Bras Med Trop 2003; 36 (02) 299-302
    CrossrefPubMedSearch in Google Scholar
  • 7 Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med 2006; 260 (04) 285-304
    CrossrefPubMedSearch in Google Scholar
  • 8 Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 2004; 53 (Pt 6): 459-475
    CrossrefPubMedSearch in Google Scholar
  • 9 Nouri M. Kamakifar P, Khodabandehlou N. et al. Association between Parvovirus B19 and anemia in HIV-infected patients. Med J Islam Repub Iran 2019; 33 (01) 835-840
    Search in Google Scholar
  • 10 Florea AV, Ionescu DN, Melhem MF. Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med 2007; 131 (05) 799-804
    CrossrefPubMedSearch in Google Scholar
  • 11 Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016; 5 (01) 210
    CrossrefPubMedSearch in Google Scholar
  • 12 Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 2010; 1 (02) 97-111
    CrossrefPubMedSearch in Google Scholar
  • 13 Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50 (04) 1088-1101
    CrossrefPubMedSearch in Google Scholar
  • 14 Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56 (02) 455-463
    CrossrefPubMedSearch in Google Scholar
  • 15 Shrikhande B, Mishra M, Qazi M. et al. Sero-prevalence of parvovirus B 19 infection among HIV positive patients attending tertiary care hospital in Central India. Arch Microbiol Immunol 2017; 01 (04) 127-132
    CrossrefSearch in Google Scholar
  • 16 Pedranti MS, Rodriguez-Lombardi G, Bracciaforte R. et al. Parvovirus B19 in HIV+ adult patients with different CD4+ lymphocyte counts. J Med Microbiol 2017; 66 (12) 1715-1721
    CrossrefPubMedSearch in Google Scholar
  • 17 LaMonte AC, Paul ME, Read JS. et al; Women and Infants Transmission Study. Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study. J Infect Dis 2004; 189 (05) 847-851
    CrossrefPubMedSearch in Google Scholar
  • 18 Kiani SJ, Javanmard D, Ghaffari H. et al. Molecular prevalence of parvovirus B19 among HIV1-infected patients in Iran. Med J Islam Repub Iran 2018; 32: 113
    PubMedSearch in Google Scholar
  • 19 Kerr JR, Kane D, Crowley B. et al. Parvovirus B19 infection in AIDS patients. Int J STD AIDS 1997; 8 (03) 184-186
    CrossrefPubMedSearch in Google Scholar
  • 20 He M, Zhu J, Yin H. et al. Human immunodeficiency virus/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China. Blood Transfus 2012; 10 (04) 502-514
    PubMedSearch in Google Scholar
  • 21 Compston LI, Li C, Sarkodie F, Owusu-Ofori S, Opare-Sem O, Allain JP. Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol 2009; 81 (11) 1860-1868
    CrossrefPubMedSearch in Google Scholar
  • 22 Chernak E, Dubin G, Henry D. et al. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 20 (01) 170-173
    CrossrefPubMedSearch in Google Scholar
  • 23 Azevedo KMLD, Setúbal S, Camacho LAB. et al. Parvovirus B19 seroconversion in a cohort of human immunodeficiency virus-infected patients. Mem Inst Oswaldo Cruz 2012; 107 (03) 356-361
    CrossrefPubMedSearch in Google Scholar
  • 24 Azadmanesh K, Mohraz M, Kazemimanesh M. et al. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV. J Med Virol 2015; 87 (07) 1124-1129
    CrossrefPubMedSearch in Google Scholar
  • 25 Aleru BO, Olusola BA, Faneye AO, Odaibo GN, Olaleye DO. Prevalence and genotypes of parvovirus B19 among HIV positive children in Ibadan, Oyo State, Nigeria. Arch Basic Appl Med 2018; 6 (01) 113-117
    PubMedSearch in Google Scholar
  • 26 Aguiar FS, Lopes DP, Bazin AR, Setúbal S, Cohen BJ, Nascimento JP. Human parvovirus B19 infection in HIV-positive patients. Rev Soc Bras Med Trop 2001; 34 (03) 239-242
    CrossrefPubMedSearch in Google Scholar
  • 27 Abdollahi A, Shoar S, Sheikhbahaei S, Mahdaviani B, Rasoulinejad M. Status of immunity against PVB19 in HIV-infected patients according to CD4(+) cell count, and antiretroviral therapy regimen groups. Niger Med J 2014; 55 (01) 20-23
    CrossrefPubMedSearch in Google Scholar
  • 28 Li X, Lin Z, Liu J. et al. Overall prevalence of human parvovirus B19 among blood donors in mainland China: a PRISMA-compliant meta-analysis. Medicine (Baltimore) 2020; 99 (17) e19832
    CrossrefPubMedSearch in Google Scholar
  • 29 Farahmand M, Tavakoli A, Ghorbani S, Monavari SH, Kiani SJ, Minaeian S. Molecular and serological markers of human parvovirus B19 infection in blood donors: a systematic review and meta-analysis. Asian J Transfus Sci 2021; 15 (02) 212-222
    CrossrefPubMedSearch in Google Scholar
  • 30 Swaine T, Ahmad N, Abbara A. et al. Parvovirus B19 induced acute severe anaemia in a well-controlled HIV-positive individual. Clin Infect Pract 2024; 21: 100334
    CrossrefSearch in Google Scholar
  • 31 Arista S, Grazia SD, Romano A, Miraglia PM, Carlo PD. Pediatric HIV infection revealed by parvovirus B19-induced anaemia. Ital J Pediatr 2003; 29 (02) 154-156
    Search in Google Scholar
  • 32 Pereira RFA, Garcia RdeC, Azevedo KMLD, Setúbal S, Siqueira MAMTD, Oliveira SAD. Clinical features and laboratory findings of human parvovirus B19 in human immunodeficiency virus-infected patients. Mem Inst Oswaldo Cruz 2014; 109 (02) 168-173
    CrossrefPubMedSearch in Google Scholar
  • 33 Hernstadt H, Randell P, Fidler S, Foster C. Tale of two viruses: parvovirus B19 and HIV. BMJ Case Rep 2021; 14 (04) e239153
    CrossrefPubMedSearch in Google Scholar
  • 34 Vaz SO, Guerra IC, Freitas MI, Marques L. Pure red cell aplasia and HIV infection: what to suspect?. BMJ Case Rep 2018; 2018: bcr-2018-224625
    CrossrefPubMedSearch in Google Scholar
  • 35 Nigro G, Luzi G, Fridell E. et al Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies. Aids 1992; 6 (07) 679-684
    CrossrefPubMedSearch in Google Scholar